Valproic acid (VPA) in patients with refractory advanced cancer: a dose escalating phase I clinical trial
Akin Atmaca(Heidelberg University), Elke Jäger(Krankenhaus Nordwest), Bernd Hentsch, Sascha Hövelmann, Štefan Schwarz(China Agricultural University), S-E. Al-Batran(Krankenhaus Nordwest), Martin Göttlicher, Alexander Maurer, Thorsten Heinzel(Friedrich Schiller University Jena), Alexander Knuth(National Center for Cancer Care and Research), Antje Neumann(Krankenhaus Nordwest)
Cited by 185
Related Papers
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
|Journal of Clinical Oncology|2000|2.3k
Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie
|Journal of Clinical Oncology|2008|784
Molecular basis of bacterial resistance to chloramphenicol and florfenicol
|FEMS Microbiology Reviews|2004|778